Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zimmer Biomet Holdings (ZBH)
NYSE:ZBH
Holding ZBH?
Track your performance easily
Earnings Data
Report Date
Feb 06, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
2.3Last Year’s EPS
2.2Same Quarter Last Year
Moderate Buy
Based on 15 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 26, 2018
|% Change Since: 5.70%
|Next Earnings Date:Jul 27, 2018
Earnings Call Sentiment|Neutral
The earnings call reflected a mix of positive and negative developments. While Zimmer Biomet demonstrated strong sales growth, product innovation, and improved pricing, challenges such as ERP implementation issues and a decline in the 'Other' category led to a lowered forecast. The resolution of ERP issues and a strong product pipeline suggest potential for future growth, but current hurdles present a balanced outlook.Company Guidance
During the Zimmer Biomet Q3 2024 earnings call, guidance was updated reflecting both challenges and achievements. The company reported a 4% increase in sales, reaching $1.824 billion, while adjusting the full-year 2024 revenue growth expectations to 4.25% to 4.75% on a constant currency basis. This adjustment considers ERP-related headwinds, which are now anticipated to impact annual sales by 60 to 80 basis points, a reduction from the initially projected 100 basis points. Despite these challenges, positive pricing trends were noted, with consolidated pricing up by 70 basis points, marking three consecutive quarters of positive pricing. The company highlighted robust performance in its knee and hip segments, with global knees growing 5.5% and global hips 3.7%, alongside notable contributions from the S.E.T. segment, which grew 7.3%. Additionally, adjusted earnings per share increased to $1.74, and free cash flow totaled $310 million for the quarter. Zimmer Biomet maintains its long-term financial commitments, including mid-single-digit revenue growth and adjusted EPS growth of at least 1.5 times revenue, with an outlook for free cash flow to grow 100 basis points faster than earnings through 2027.Strong Sales Growth
Zimmer Biomet reported mid-single-digit sales growth in Q3, marking the 11th consecutive quarter of such growth, with particularly strong performance in knees, hips, and S.E.T. segments.
Positive Pricing Environment
Consolidated pricing was positive for the third consecutive quarter, driven by improved market conditions and strategic pricing governance.
Product Innovation and Launches
The company highlighted a robust product pipeline with over 50 planned launches, including the Z1 triple taper hip stem and ROSA surgical platforms, which are expected to drive future growth.
Improved ERP Impact Outlook
The ERP-related sales impact was revised down to 60-80 basis points, better than the initially expected 100 basis points, with normalization expected by year-end.
Strong Cash Flow and Share Buybacks
Zimmer Biomet generated $310 million in free cash flow and repurchased approximately $600 million in shares, reaffirming its commitment to return capital to shareholders.
---
ZBH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ZBH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 30, 2024 | $103.65 | $109.56 | +5.70% |
| Aug 07, 2024 | $109.08 | $105.34 | -3.43% |
| May 02, 2024 | $118.76 | $117.67 | -0.92% |
| Feb 08, 2024 | $126.46 | $121.99 | -3.53% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Zimmer Biomet Holdings (ZBH) report earnings?
Zimmer Biomet Holdings (ZBH) is schdueled to report earning on Feb 06, 2025, TBA Not Confirmed.
What is Zimmer Biomet Holdings (ZBH) earnings time?
Zimmer Biomet Holdings (ZBH) earnings time is at Feb 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ZBH EPS forecast?
ZBH EPS forecast for the fiscal quarter 2024 (Q4) is 2.3.
---